Literature DB >> 10049356

Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.

R J Grumont1, I J Rourke, S Gerondakis.   

Abstract

In response to different extracellular signals, Rel/NF-kappaB transcription factors are critical regulators of apoptosis in a variety of cell types. Here we show that in normal B and T cells, expression of the Bcl-2 prosurvival homolog, A1, is rapidly induced in a Rel-dependent manner by mitogens. In B-cell lines derived from c-rel-/- mice, which like primary cells lacking Rel undergo apoptosis in response to antigen receptor ligation, constitutive expression of an A1 transgene inhibits this pathway to cell death. These findings are the first to show that Rel/NF-kappaB regulates physiologically the expression of a Bcl-2-like protein that is critical for the control of cell survival during lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049356      PMCID: PMC316474          DOI: 10.1101/gad.13.4.400

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

Review 1.  The Bcl-2 protein family: arbiters of cell survival.

Authors:  J M Adams; S Cory
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 2.  The turnover of B-cell populations.

Authors:  D G Osmond
Journal:  Immunol Today       Date:  1993-01

Review 3.  Programmed cell death, apoptosis and killer genes.

Authors:  L M Schwartz; B A Osborne
Journal:  Immunol Today       Date:  1993-12

Review 4.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

Authors:  C Y Wang; M W Mayo; R G Korneluk; D V Goeddel; A S Baldwin
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

6.  High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro.

Authors:  C Abbadie; N Kabrun; F Bouali; J Smardova; D Stéhelin; B Vandenbunder; P J Enrietto
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

Review 8.  Programmed cell death in Caenorhabditis elegans.

Authors:  M O Hengartner; H R Horvitz
Journal:  Curr Opin Genet Dev       Date:  1994-08       Impact factor: 5.578

9.  rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.

Authors:  R J Grumont; I B Richardson; C Gaff; S Gerondakis
Journal:  Cell Growth Differ       Date:  1993-09

10.  Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells.

Authors:  K Miyake; Y Yamashita; Y Hitoshi; K Takatsu; M Kimoto
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  104 in total

1.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

Authors:  H H Lee; H Dadgostar; Q Cheng; J Shu; G Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.

Authors:  C Y Wang; D C Guttridge; M W Mayo; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Mechanisms of apoptosis.

Authors:  J C Reed
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

4.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Authors:  Hajir Dadgostar; Brian Zarnegar; Alexander Hoffmann; Xiao-Feng Qin; Uyen Truong; Govinda Rao; David Baltimore; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 5.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

6.  Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.

Authors:  Béatrice Rayet; Yongjun Fan; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 7.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

8.  Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.

Authors:  Vassiliki Poulaki; Constantine S Mitsiades; Antonia M Joussen; Alexandra Lappas; Bernd Kirchhof; Nicholas Mitsiades
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

9.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation.

Authors:  Brendan A Hilliard; Nicola Mason; Lingyun Xu; Jing Sun; Salah-Eddine Lamhamedi-Cherradi; Hsiou-Chi Liou; Christopher Hunter; Youhai H Chen
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.